Ankara University Medical School is a medical school located in the Sıhhiye district of Ankara, Turkey. It opened in 1945 as the second medical school in Turkey, when Istanbul Medical School could no longer keep up with the demand for trained doctors.

During the past decade, Ankara University School of Medicine conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 9 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ankara University School of Medicine" #1 sponsor was "Ankara University" with 6 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Nanfang Hospital of Southern Medical University" with 3 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Actelion" with 1 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara University School of Medicine" #1 collaborator was "Ankara University" with 4 trials as a collaborator, "LanZhou University" with 4 trials as a collaborator, "Xingtai People's Hospital" with 4 trials as a collaborator, "Shandong Provincial Hospital" with 3 trials as a collaborator and "Southern Medical University, China" with 3 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Ankara University School of Medicine" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Acute Pain" (1 trials), "Anemia of Prematurity" (1 trials), "Anesthesia, Spinal" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Ankara University School of Medicine" in a lesser frequency.

Most popular intervention types in "Ankara University School of Medicine" are "Drug" (18 trials), "Other" (5 trials), "Diagnostic Test" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dexamethasone" (2 trials), "Nintedanib" (2 trials), "ACP-001" (1 trials) and "ACT-064992 (macitentan)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ankara University School of Medicine" are 29 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ankara University School of Medicine". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Ankara University School of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ankara University School of Medicine, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".